Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing
For information about when drugs will be coming off patent
— Pharmacist, UK
To profile life cycle initiatives for branded products
— Head product development group, India
For information about medicines -- patent expiration dates, title, terms, etc.
— Pharmaceutical regulatory affairs, Mexico
To identify APIs going off-patent in the next few years
— API manufacturer, India
To check for drug patent status in MENA
— Pharmaceutical manufacturer, USA
Generated: May 27, 2017
Which patents cover Xopenex Hfa, and when can generic versions of Xopenex Hfa launch?
Xopenex Hfa is a drug marketed by Sunovion and is included in one NDA. There are two patents protecting this drug.| Patents: | 2 |
| Applicants: | 1 |
| NDAs: | 1 |
| Suppliers / Packagers: see list | 4 |
| Clinical Trials: see list | 79 |
| Drug Prices: | see details |
| DailyMed Link: | XOPENEX HFA at DailyMed |
| Drug Class | beta2-Adrenergic Agonist |
| Mechanism of Action | Adrenergic beta2-Agonists |
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sunovion | XOPENEX HFA | levalbuterol tartrate | AEROSOL, METERED;INHALATION | 021730-001 | Mar 11, 2005 | RX | Yes | Yes | 7,256,310 | ► Subscribe | Y | Y | ► Subscribe | ||||||||||||||||
Sunovion | XOPENEX HFA | levalbuterol tartrate | AEROSOL, METERED;INHALATION | 021730-001 | Mar 11, 2005 | RX | Yes | Yes | 8,765,153 | ► Subscribe | Y | ► Subscribe | |||||||||||||||||
Sunovion | XOPENEX HFA | levalbuterol tartrate | AEROSOL, METERED;INHALATION | 021730-001 | Mar 11, 2005 | RX | Yes | Yes | ► Subscribe | ► Subscribe | |||||||||||||||||||
| This preview shows a limited data set Subscribe for full access, or try a Trial | |||||||||||||||||||||||||||||
Export unavailable in trial.
Subscribe for complete access.
Expired Orange Book Patents
Available with subscription
Paragraph IV Activity
Available with subscription
Patent Maintenance
Available with subscription
Non-Orange Book Patents
Available with subscription
International Patents
Available with subscription
Supplementary Protection Certificates
Available with subscription
To gain knowledge of expiry of patents in anticipation of generic/biosimilars entering the market
— Clinical pharmacist, state drug formulary committee, USA
To know the expiration dates of several pharmaceuticals products
— Pharmaceutical company, Spain
To get information on ANDA & Paragraph IV challenges
— Global head business team (API & generics), Netherlands
For drug patent information
— Pharmaceutical business developer, USA
To find expiration dates for patents on chemotherapy medicines
— Program manager, non-profit, USA
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639
Follow DrugPatentWatch:
